Prevenar 20

BIOLOGICAL3 trials

Sponsors

Pfizer, Pfizer Inc., GlaxoSmithKline Biologicals SA

Conditions

HealthyPneumococcal Disease PaediatricsVaccines - Group B Streptococcus

Phase 1

A trial to evaluate the safety and reactogenicity of an investigational pneumococcal vaccine in toddlers 12 to 15 months of age receiving a single booster dose

Active, not recruitingPACTR202605631649775

GlaxoSmithKline Biologicals SAPneumococcal Disease Paediatrics

Start: 2026-05-15Target: 45Updated: 2026-06-22

Phase 3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

RecruitingNCT07160244

Start: 2025-08-25End: 2029-03-02Target: 6000Updated: 2026-07-09

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Active, not recruitingPACTR202603734617942

Pfizer Inc.Vaccines - Group B Streptococcus

Start: 2026-09-14Target: 1300Updated: 2026-06-22